Medinol has announced that it obtained CE-mark for EluNIR, its novel Drug Eluting Stent featuring a unique stent design with low metal footprint and a proprietary elastomeric coating, both designed to optimise clinical outcomes. EluNIR demonstrated outstanding outcomes in two randomised pivotal studies.
Panasonic PhotoMOS® Photovoltaic MOSFET High-Power Drivers
Adam-Tech Wire-to-Board Solutions